Investment
Features
FeesSafety
Academy
More
Pluang+

Tokenized stock values on Ethereum, BNB Chain, and Solana show inconsistent data, no clear market leader.

Market News
20 Oct 2026
Tokenpost
View Source
Neutral
Tokenized stock values on Ethereum, BNB Chain, and Solana show inconsistent data, no clear market leader.

Recent reports show tokenized stock values on Ethereum at $210.9 million, BNB Chain at $115.7 million, and Solana at $78.5 million. However, earlier data showed BNB Chain leading with $1.5 billion, Ethereum at $842.4 million, and Solana at $732.2 million. These discrepancies arise from differences in measurement scope and timing, making it unclear which network leads in tokenized stock value. Tokenized stocks represent blockchain-based exposure to traditional shares, distinct from native cryptocurrency values on these networks.

The story on tokenized-stock valuations across blockchain networks provides context for readers. For those tracking major cryptocurrencies on Pluang, as of Oct 21, 2026 03:41 WIB, 45 of 50 major cryptocurrencies rose while 4 fell. Notable price changes include AXS up 5.20% at Rp18.925 with 100% sell order activity, SNX up 4.96% at Rp4.060 with 75% buy order activity, and MANA up 4.74% at Rp1.569 with 87% sell order activity and a typical hold time of 157 days.

More News

Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...

Company Fundamentals
Neutral
19 minutes ago
Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...

Company Fundamentals
Bullish
22 minutes ago
Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
1 hour ago
Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
2 hours ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App